Able Innovations Inc.: federal grants and contributions: 22 agreements; $3.8M value; 2 departments; 8 programs.
Assay record ASY-CA-1Y6LL5L0MM · Cite as: Assay Systems, “Able Innovations Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/able-innovations-inc/
The purpose of the project is to establish a manufacturing facility to accelerate the commercialization of the company’s ALTA device, a lateral patient transfer device.
To support the establishment of a manufacturing facility for lateral patient transfer (ALTA) device and accelerate the commercialization of this product.
To support the establishment of a manufacturing facility for lateral patient transfer (ALTA) device and accelerate the commercialization of this product.
Through this project Able Innovations will focus on the improvements to and development of specific critical sub-systems within the ALTA platform which affect the comfort, HMI, propulsion of the device and cleaning/disinfection.
Development of commercial product that is able to conduct autonomous lateral transfers in a CT Scan suite. Our self-cleaning device will allow a single caregiver to conduct transfers without risking infection from patients or injury.
This project will allow for Able Innovations' Alta Platform™ to expand its use-cases within the clinical setting, leading to increased adoption and superior client experience.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
Hiring of two recent graduates to join Able Innovation's R&D team. In particular, the new graduate will develop a novel delivery mechanism for the transfer platform (currently being developed under project 914250) that can collapse so it can be stored, as well as lift individuals who have fallen to the ground.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
New engineering graduate will work to assist in design of disinfection system, gauges & fixtures as well as assistance regulatory affairs.
Able Innovations will engage in a project to prototype and test a novel patient transfer device that allows for transfer to be performed without physical strain. This device will reduce the risk and rates of injuries to caregivers and patients, as well as free up overhead in healthcare facilities. This project will focus on the detailed design, analysis as well as experimental development of the novel transfer device with a goal to understand and address technical uncertainties.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
This position will anchor Able Innovations' Marketing and Business development initiatives by overseeing and generating external facing media to build Able Innovations' brand as a leader in Hospital Innovation globally.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Development of electromechanical system and its systems to allow for ease of operation and safety.
Through this project Able Innovations will focus on the improvements to and development of specific critical sub-systems within the ALTA platform which affect the comfort, HMI, propulsion of the device, and cleaning/disinfection.
Able Innovations is testing & implementing the ALTA Platform at five different hospital facilities as a part of their Change Leadership Initiative. This project directly supports the new intern involved in the project execution by creating product and project documentation, interacting with the staff and patients, training and demonstrating the product, and marketing the technology in front of hospital stakeholders.
Able Innovations is advancing the commercialization of ALTA Platform, a medical robotics device designed to enable a single caregiver to conduct patient transfer in a safe, efficient & dignified manner. This Youth hire will focus on market research, business development, and client engagement to drive adoption and scalability.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
All grants from Federal Economic Development Agency for Southern Ontario
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.